Skip to main content
. 2020 Jun 26;2(2):fcaa086. doi: 10.1093/braincomms/fcaa086

Table 4.

Pairwise contrasts of interest derived from mixed-effects models introduced in Figs 7 and 8

Figure Y Contrast Estimate Standard error P value
7 F PLA clusters/μm EGFP-CAP2/Myc-(C32G)CAP2-CTRL versus EGFP-CAP2/Myc-CAP2-CTRL −0.5914 0.1777 <0.0001
EGFP-CAP2/Myc-(C32G)CAP2-cLTP versus EGFP-CAP2/Myc-CAP2-CTRL −0.6388 0.1777 0.00129
EGFP-CAP2/Myc-CAP2-cLTP versus EGFP-CAP2/Myc-CAP2-CTRL 0.5791 0.1640 0.00129
EGFP-CAP2/Myc-(C32G)CAP2-cLTP versus EGFP-CAP2/Myc-(C32G)CAP2-CTRL −0.0475 0.1894 0.8030
EGFP-CAP2/Myc-CAP2-cLTP versus EGFP-CAP2/Myc-(C32G)CAP2-CTRL 1.1705 0.1777 <0.0001
EGFP-CAP2/Myc-CAP2(C32G)-cLTP versus EGFP-CAP2/Myc-CAP2-cLTP −1.2180 0.1777 <0.0001
7 H PLA clusters/μm Myc-(C32G)CAP2/Cofilin-CTRL versus Myc-CAP2/Cofilin-CTRL −0.0178 0.0104 0.115
Myc-(C32G)CAP2/Cofilin-cLTP versus Myc-CAP2/Cofilin-CTRL −0.0001 0.0096 0.9901
Myc-CAP2/Cofilin-cLTP versus Myc-CAP2/Cofilin -CTRL 0.0668 0.0096 <0.0001
Myc-(C32G)CAP2/Cofilin -cLTP versus Myc-(C32G)CAP2/Cofilin-CTRL 0.0177 0.0102 0.115
Myc-CAP2/Cofilin-cLTP versus Myc-(C32G)CAP2/Cofilin-CTRL 0.0846 0.0102 <0.0001
Myc-(C32G)CAP2/Cofilin-cLTP versus Myc-CAP2/Cofilin-cLTP −0.0669 0.0094 <0.0001
8 B IntDen Cofilin/IntDen RFP CAP2-shRNA-cLTP versus SCR-CTRL −0.0051 0.0243 0.834
SCR-cLTP versus SCR-CTRL 0.0992 0.0218651 <0.0001
shRNA + shr-C32G-CAP2-cLTP versus SCR-CTRL 0.0245 0.0240298 0.386
shRNA + shr-wt-CAP2-cLTP versus SCR-CTRL 0.1386 0.0239044 <0.0001
CAP2-shRNA-cLTP versus SCR-cLTP −0.09412 0.0236968 0.00016
CAP2-shRNA-cLTP versus shRNA + shr-C32G-CAP2-cLTP −0.01937 0.0250532 0.489
CAP2-shRNA-cLTP versus shRNA + shr-wt-CAP2-cLTP −0.1335 0.0238909 <0.0001
shRNA + shr-C32G-CAP2-cLTP versus SCR-cLTP −0.07475 0.0233884 0.00246
shRNA + shr-wt-CAP2-cLTP versus SCR-cLTP 0.0394 0.0231644 0.128
shRNA + shr-C32G-CAP2-cLTP versus shRNA + shr-wt-CAP2-cLTP −0.1142 0.0240324 <0.0001
8 D Spine length CAP2-shRNA-cLTP versus SCR-CTRL 0.3468 0.0173 <0.0001
SCR-cLTP versus SCR-CTRL 0.2984 0.0177 <0.0001
shRNA + shr-C32G-CAP2-cLTP versus SCR-CTRL 0.3676 0.0165 <0.0001
shRNA + shr-wt-CAP2-cLTP versus SCR-CTRL 0.1881 0.0184 <0.0001
CAP2-shRNA-cLTP versus SCR-cLTP 0.0484 0.0180 0.00795
shRNA + shr-C32G-CAP2-cLTP versus CAP2-shRNA-cLTP 0.0207 0.0171 0.2255
shRNA + shr-wt-CAP2-cLTP versus CAP2-shRNA-cLTP −0.1588 0.0187 <0.0001
shRNA + shr-C32G-CAP2-cLTP versus SCR-cLTP 0.0691 0.0171 <0.0001
shRNA + shr-wt-CAP2-cLTP versus SCR-cLTP −0.1104 0.0187 <0.0001
shRNA + shr-C32G-CAP2-cLTP versus shRNA + shr-wt-CAP2-cLTP 0.1795 0.0184 <0.0001
Spine width CAP2-shRNA-cLTP versus SCR-CTRL 0.0116 0.0094 0.2185
SCR-cLTP versus SCR-CTRL 0.2100 0.0096 <0.0001
shRNA + shr-C32G-CAP2-cLTP versus SCR-CTRL −0.0473 0.0090 <0.0001
shRNA + shr-wt-CAP2-cLTP versus SCR-CTRL 0.2821 0.0100 <0.0001
CAP2-shRNA-cLTP versus SCR-cLTP −0.1984 0.0098 <0.0001
shRNA + shr-C32G-CAP2-cLTP versus CAP2-shRNA-cLTP −0.0589 0.0093 <0.0001
shRNA + shr-wt-CAP2-cLTP versus CAP2-shRNA-cLTP 0.2705 0.0102 <0.0001
shRNA + shr-C32G-CAP2-cLTP versus SCR-cLTP −0.2573 0.0093 <0.0001
shRNA + shr-wt-CAP2-cLTP versus SCR-cLTP 0.0721 0.0102 <0.0001
shRNA + shr-C32G-CAP2-cLTP versus shRNA + shr-wt-CAP2-cLTP −0.3294 0.0100 <0.0001

P values were derived after adjustment for multiple comparisons according to the false discovery rate (FDR) approach.